secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2026-05-29T12:39:28+00:00
Accession:  0001628280-26-039005
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD resumes ChloraPrep shipments after voluntary hold; all final release testing acceptable
--------------------------------------------------------------------------------

- BD voluntarily placed ChloraPrep and PurPrep on ship hold on May 6, 2026 for additional final release testing.
- Shipments of ChloraPrep have resumed in the U.S. after completion of additional assessments and testing.
- All additional final release testing performed to date has been acceptable; no patient safety signals.
- The ship hold was in response to the FDA Warning Letter for the El Paso manufacturing facility.
- Detailed risks associated with the Warning Letter are described in BD's Q1 FY2026 10-Q filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000162828026039005/0001628280-26-039005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000162828026039005/bdx-20260529.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-039005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer